TyroSphere Beads
Hypervascular Tumors (e.g., Liver Cancer)
Pre-clinical / FeasibilityActive
Key Facts
Indication
Hypervascular Tumors (e.g., Liver Cancer)
Phase
Pre-clinical / Feasibility
Status
Active
Company
About REVA Medical
REVA Medical is a pioneer in bioresorbable polymer technology, having developed 19 polymer families over two decades. Its proprietary Tyrocore polymer platform underpins its commercial and pipeline products, including the CE-marked Fantom Encore coronary scaffold and the MOTIV BTK scaffold, which has FDA Breakthrough Designation. The company's strategy targets the large cardiovascular device market by offering temporary scaffolds that resorb, aiming to improve long-term patient outcomes compared to permanent metal implants. REVA operates as a commercial-stage entity in select European markets while advancing clinical programs for US market entry.
View full company profile